PATENT CLAIM ANALYSIS

Application Number: 16153532
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-10
Patent Classification: ["514", "019300"]

Abstract:
Disclosed are newly identified chemotherapeutic agents. These inhibitors are particularly useful in the treatment of cancers such as leukemic cells and pancreatic cancers.

Claim (Index 8):
A method for killing multiple myeloma cells which method comprises contacting said cells with an effective amount of a pharmaceutical composition of  claim 6 .

Metadata:
- Claim Count in Document: 15.0
- Percentile: 97.0
- Lexical Diversity: 1.13636
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12671287', '13164204', '11497511', '14769331', '15510217']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7515895394512508
- 35 USC 102 Novelty (BERT): 0.4944231621566001
- Combined Prediction Score: 0.7258729017217858
- Mean Citation Score: 160.218004
- Max Citation Score: 164.74771
- Similarity Product: 102.8692392994237

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test